Compare arstasis vs Vascular Control Systems
Customers evaluate the quality of arstasis's products using the following success metrics.
Overview
arstasis is 20 yrs old and is based in United States.
Arstasis develops vascular access devices designed to provide better solutions for arterial closure in catheterization procedures. The AXERA Access Device is a femoral artery access tool that quickly creates a longer and shallower angle arteriotomy, resulting in significant tissue-upon-tissue overlap through the artery. Upon sheath removal, arterial pressure decreases across this longer Arstaotomy channel providing an excellent environment for clot formation and rapid hemostasis. The AXERA Device's Arstaotomy Procedure requires only minimal compression to provide secure closure with no foreign body implants - eliminating the risk of infections and thomboembolic events related to implants. The Arstaotomy Procedure promotes rapid hemostasis resulting in excellent patient comfort with decreased bed rest and quicker ambulation.
Vascular Control Systems is based in United States
Vascular Control Systems is a privately held company focused on developing medical devices to treat fibroids and to control bleeding in obstetric and gynecologic applications.
Demo Video
Leadership
Alexander Arrow (Chief Financial Officer)
Greg Altieri (Chief Executive Officer, President)
Investors
New Enterprise Associates, GDN Holdings
Ethicon and MedVenture Associates
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because arstasis has not claimed their profile.
Work for arstasis? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for arstasis?
Claim your profile now.
Information not available because Vascular Control Systems has not claimed their profile.
Work for Vascular Control Systems? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Vascular Control Systems?
Claim your profile now.